n-acetyltalosaminuronic acid has been researched along with Hepatitis B Virus Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busch, M; Kleinman, S; Lelie, N | 1 |
| Chudy, M; Fiedler, SA; Funk, M; Halbauer, J; Heiden, M; Henseler, O; Oberle, D; Scheiblauer, H | 1 |
2 other study(ies) available for n-acetyltalosaminuronic acid and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Residual risk of transfusion-transmitted hepatitis B virus (TT-HBV) infection by NAT-screened blood components: A review of observed versus modeled infectivity from donors with window period and occult HBV infections.
Topics: Blood Donors; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Risk; Torque teno virus; Uronic Acids | 2021 |
Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
Topics: Germany; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis C; HIV Infections; HIV-1; Humans; Immunoassay; Mass Screening; Serologic Tests; Uronic Acids | 2019 |